Key Growth Strategies Adopted by the Major Players in Plant Activators Market

By -

The plant activators market stood at USD 597.14 Million in 2017; it is projected to grow at a CAGR of 6.6% from 2018, to reach USD 878.38 Million by 2023.

(EMAILWIRE.COM, March 21, 2019 ) The plant activators market is projected to grow at a CAGR of 6.6%, to reach a value of USD 878.38 million by 2023 from USD 636.76 million in 2018. The key players profiled in the report have a strong presence in the global plant activators market; these include Syngenta (Switzerland), Isagro (Italy), Plant Health Care (US), Arysta LifeScience (US), Nihon Nohyaku Co., Ltd. (Japan), Meiji Seika (Japan), Certis (US), Gowan (US), Futureco Bioscience (Spain), NutriAg (Canada), and Eagle Plant Protect Pvt. Ltd. (India).

These players adopted growth strategies such as expansions, investments, mergers, and acquisitions to cater to the increasing demand for plant activators. Companies have been expanding their operations in various geographies across the globe to establish themselves as leading players in the plant activators market. The core strength of the key players is strategic expansions, which are undertaken to enhance their presence in the plant activators market.

Download PDF Brochure
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103570996

Companies such as Syngenta and Isagro focus on expanding their manufacturing capacities of plant activators to strengthen their presence in the market. Some key companies also adopted strategies such as mergers and acquisitions to expand their reach geographically.

Syngenta, one of the global leaders in the plant activators market, offers a wide range of plant activator products to increase crop yield and improve food quality. The company has advanced manufacturing facilities in Switzerland, the US, the UK, France, India, China, and Brazil. Syngenta focuses on strengthening its market position by adopting strategies such as expansions by setting up new facilities as well as expanding the capacities of its existing facilities. In October 2016, Syngenta invested USD 240 million to set up production facilities in Brazil and Switzerland, which expanded its production capacity to cater to the increasing demand for plant activators in these countries.

Speak to Analyst
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=103570996

Arysta LifeScience is a global specialty chemicals manufacturing company, primarily engaged in offering a wide range of products such as insecticides, herbicides, fungicides, biostimulants, and other value-added nutrients. In June 2017, Arysta LifeScience acquired Verios Agro Pty Ltd (South Africa) and Veriprod Pty Ltd (South Africa) (collectively, "Verios"). This acquisition helped the company increase its presence in the African market. The company focuses on offering a diverse range of plant activators products that adhere to the government policies and regulations of different regions.


Media Contact

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more